Browsing by Author Wijeyakumar, Wijeyanthy

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2014Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular DegenerationBroadhead, Geoffrey; Chang, Andrew; Schlub, Timothy; Wijeyakumar, Wijeyanthy; Zhu, Meidong; Hong, Thomas; Li, Haitao; Molecular Bioscience; Northern Clinical School: Clinical Ophthal & Eye Health; Central Clinical School: Medicine; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration, Ophthalmology, vol.121, 1, 2014,pp 188-192
2015Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age-related macular degenerationBroadhead, Geoffrey; Chang, Andrew; Schlub, Timothy; Wijeyakumar, Wijeyanthy; Zhu, Meidong; Hong, Thomas; Li, Haitao; Central Clinical School: Save Sight & Eye Health Inst.; Northern Clinical School: Clinical Ophthal & Eye Health; Central Clinical School: Medicine; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age-related macular degeneration, Retina: the Journal of Retinal and Vitreous Diseases, vol.35, 5, 2015,pp 975-981
2017Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degenerationBroadhead, Geoffrey; Chang, Andrew; Syed, Adil; Wijeyakumar, Wijeyanthy; Zhu, Meidong; Hong, Thomas; Joachim, Nichole; Li, Haitao; Luo, Kehui; Central Clinical School: Save Sight & Eye Health Inst.; Northern Clinical School: Clinical Ophthal & Eye Health; Medicine; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration, Graefes Archive for Clinical and Experimental Ophthalmology, vol.255, 3, 2017,pp 475-484